High levels of women's satisfaction and compliance with transdermal contraception: Results from a European multinational, 6-month study

Gynecological Endocrinology

Volumn 27, Issue 10, 2011, Pages 849-856

  Jakimiuk, A J ^a   Crosignani, P G ^b   Chernev, T ^c   Prilepskaya, V ^d   Bergmans, P ^e   Von Poncet, M ^e   Marelli, S ^e   Lee, E J ^e  

^a INSTITUTE OF MOTHER AND CHILD   (Poland)

^b UNIVERSITY OF MILAN   (Italy)

^c University Maternity Hospital Maichin Dom   (Bulgaria)

^d INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^e Medical Affairs ^*  (Belgium)

Author keywords

compliance; hormonal contraception; preference; satisfaction; Transdermal patch

Indexed keywords

ETHINYLESTRADIOL PLUS NORELGESTROMIN;

ADULT; ARTICLE; BARRIER CONTRACEPTION; CONTRACEPTION; DIPLOPIA; DRUG SAFETY; DRUG TOLERABILITY; EXOPHTHALMOS; FEMALE; GRAVES DISEASE; HEADACHE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MASTALGIA; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PATIENT PREFERENCE; PATIENT SATISFACTION; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE; RADICULITIS; SELF REPORT; TRANSDERMAL PATCH;

ADOLESCENT; ADULT; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; ETHINYL ESTRADIOL; EUROPE; FEMALE; HUMANS; MIDDLE AGED; NORGESTREL; PATIENT PREFERENCE; PATIENT SATISFACTION; PREGNANCY; PREGNANCY RATE; QUALITY OF LIFE; SELF REPORT; TRANSDERMAL PATCH; YOUNG ADULT;

EID: 80053915578     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.538095     Document Type: Article

References (24)

1. Graziottin A. A review of transdermal hormonal contraception. Focus on the ethinylestradiol/norelgestromin contraceptive patch. Treat Endocrinol 2006;5:359-365
2. Graziottin A. Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review. Patient Prefer Adherence 2008;2:357-367
3. Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril 2002;77:S13-S18
4. Burkman RT. Transdermal hormonal contraception: benefits and risks. Am J Obstet Gynecol 2007;197:134e1-134e6
5. Jick SS, Kaye JA, Russmann S, Jick H. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 mg of ethyl estradiol. Contraception 2006;73:223-228
6. Jick S, Kaye JA, Li L, Jick H. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 mg of ethinyl estradiol. Contraception 2007;76:4-7
7. Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 2007;109 (2 Pt 1):339-346
8. Jick SS, Hagberg KW, Hernandez RK, Kaye JA. Postmarketing study of ORTHO EVRA1 and levonogestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. Contraception 2010;81:16-21
9. Dore DD, Norman H, Seeger JD. Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive users. Letter to the editor of Obstet Gynecol 2009;114:175
10. Dore DD, Norman H, Loughlin J, Seeger JD. Extended casecontrol study results on thromboembolic outcomes among transdermal contraceptive users. Contraception 2010;81:408-413
11. Wan GJ, Barnowski CE, Ambegaonkar BM, Bolge SC, McDonnell DD. Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives. Contraception 2007;73:281-284
12. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assessment of compliance with a weekly contraceptive patch (Ortho EvraTM/EvraTM) among North American Women. Fertil Steril 2002;77 (suppl 2):S27-S31
13. Urdl W, Apter D, Alperstein A, Koll P, Schonian S, Bringer J, Fisher AC, Preik M. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 2005;121:202-210
14. Lopez LM, Grimes DA, Gallo MF, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception (Review). The Cochrane Collaboration. Wiley; 2008
15. Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, Creasy GW. Evaluation of ontraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive: a randomized controlled trial. JAMA 2001;285:2347-2354
16. Archer DF, Cullins V, Creasy GW, Fisher AC. The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. Contraception 2004;69:189-195
17. Crosignani PG, Nappi C, Ronsini S, Bruni V, Marelli S, Sonnino D; and the EVRA Contrast Study Group. Satisfaction and compliance in hormonal contraception: the result of a Multicentre Clinical Study on Women's Experience with theethinylestradiol/norelgestromin contraceptive patch in Italy. BMC Woman's Health 2009;9:18
18. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233
19. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. How to score Version 2 of the SF-12 Health Survey (with a supplement documenting version 1). Boston: QualityMetric Incorporated; 2004
20. Weisberg F, Bouchard C, Moreau M, Audet MC, Mawdsley S, Dattani D, Dinniwell J, Horbay GL. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study. J Obstet Gynaecol Can 2005;27:350-359
21. Creasy GW, Abrams LS, Fisher AC. Transdermal contraception. Semin Reprod Med 2001;19:373-380
22. Smallwood GH, Meador ML, Lenihan JP, Shangold GA, Fisher AC, Creasy GW. Efficacy and safety of a transdermal contraceptive system. Obstet Gynecol 2001;98:799-805
23. Richter A, Anton SE, Koch P, Dennett SL. The impact of reducing dose frequency on health outcomes. Clin Ther 2003;25:2307-2335
24. Gallo MF, Grimes DA, Schulz KF. Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev 2003;CD003552